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Abstract
Background: GABAergic signals to the nucleus accumbens (NAc) shell arise from predominantly subcortical sources
whereas glutamatergic signals arise mainly from cortical-related sources. Here we contrasted GABAergic and glutamatergic
generation of hedonics versus motivation processes, as a proxy for comparing subcortical and cortical controls of emotion.
Local disruptions of either signals in medial shell of NAc generate intense motivated behaviors corresponding to desire
and/or dread, along a rostrocaudal gradient. GABA or glutamate disruptions in rostral shell generate appetitive motivation
whereas disruptions in caudal shell elicit fearful motivation. However, GABA and glutamate signals in NAc differ in important
ways, despite the similarity of their rostrocaudal motivation gradients.
Methodology/Principal Findings: Microinjections of a GABAA agonist (muscimol), or of a glutamate AMPA antagonist
(DNQX) in medial shell of rats were assessed for generation of hedonic ‘‘liking’’ or ‘‘disliking’’ by measuring orofacial affective
reactions to sucrose-quinine taste. Motivation generation was independently assessed measuring effects on eating versus
natural defensive behaviors. For GABAergic microinjections, we found that the desire-dread motivation gradient was
mirrored by an equivalent hedonic gradient that amplified affective taste ‘‘liking’’ (at rostral sites) versus ‘‘disliking’’ (at
caudal sites). However, manipulation of glutamatergic signals completely failed to alter pleasure-displeasure reactions to
sensory hedonic impact, despite producing a strong rostrocaudal gradient of motivation.
Conclusions/Significance: We conclude that the nucleus accumbens contains two functional affective keyboards for amino-
acid signals: a motivation-generating keyboard and a hedonic-generating keyboard. Corticolimbic glutamate signals and
subcortical GABA signals equivalently engage the motivation keyboard to generate desire and-or dread. Only subcortical
GABA signals additionally engage the hedonic keyboard to amplify affective ‘‘liking’’ and ‘‘disliking’’ reactions. We thus
suggest that top-down cortical glutamate signals powerfully regulate motivation components, but are relatively unable to
penetrate core hedonic components of emotion. That may carry implications of limits to therapeutic regulation of
pathological emotions.
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Introduction
Local activation of GABAA receptors or localized blockade of
glutamate AMPA receptors in the medial shell of NAc each
generate intense levels of motivated appetitive or fearful behaviors
in an anatomically organized pattern of valence. Desire versus
dread is generated by both GABAergic and glutamatergic
microinjections along a rostrocaudal gradient in medial shell, in
a manner analogous to a limbic ‘affective keyboard’ [1,2,3,4,5,6].
Just as a keyboard generates many notes, neurochemical
manipulations at different rostrocaudal points in medial shell
generate many graded combinations of appetitive and/or
defensive behaviors [3,4,5].
For example, in the rostral 25% of medial shell, microinjections of
the GABAA agonist muscimol or the glutamate AMPA-kainate
antagonist DNQX each generate high levels of pure appetitive
behaviors such as eating or drinking [1,7,8,9,10]. By contrast, near
the rostrocaudal midpoint of shell muscimol or DNQX microinjec-
tions generate bivalent mixtures of both appetitive and fearful
reactions. The fearful reactions include species-specific defensive
behaviors such as distress vocalizations, escape attempts, conditioned
place avoidance and defensive treading [2,3,4,5,6]. Defensive
treading in particular occurs in the wild as an instinctive anti-
predator behavior used to kicksand at snakes or other natural threats,
and in the laboratory to bury or build protective mounds against
small localized shock prods or other noxious objects [5,6,11,12]. In
the caudal 25% of medial shell, high levels of these fearful behaviors
are elicited relatively purely by microinjections of the same drugs,
whereas appetitive behaviors become suppressed [5,6].
Therefore, similar appetitive-fearful behaviors are generated by
glutamatergic and GABAergic microinjections at appropriate
points along this rostrocaudal gradient in medial shell. But
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Glutamate blockade in medial shell primarily blocks the impact of
excitatory glutamate release by cortical-related projections
from regions of neocortex (e.g., prefrontal cortex), and from
cortical-type forebrain structures (e.g., basolateral amygdala and
hippocampus), and corticolimbic relay nuclei (e.g., thalamus
paraventricular nucleus) [1,13,14,15,16,17] (Fig. 1). GABA signals
arise primarily from subcortical circuits, and muscimol more
directly modulates intrinsic spiny neurons of medial shell,
mimicking inputs from collateral axons from other spiny NAc
neurons and from ventral pallidum projections and projections
from the ventral tegmental area, and related subcortical sources
[1,18,19,20,21,22] (Fig. 1). These differences suggest that GABA
signals to NAc function essentially as bottom-up signals whereas
glutamate signals function more heavily as top-down glutamate
signals. These differences may carry functional implications for the
generation of desire and dread emotions, despite their outward
similarities in motivated behavior of eating versus defensive
treading, distress calls, etc.
To probe this issue, here we contrasted GABAergic versus
glutamatergic manipulations of medial shell for generation of 1)
hedonic ‘liking’ shifts, measured in affective reactions to sucrose-
quinine tastes, and 2) motivation gradients of appetitive and fearful
behaviors as described above. We report that despite generating
comparable levels of fear and feeding behaviors, only GABA
manipulation in medial shell simultaneously shifts the hedonic
impact of a sensory pleasure or displeasure. By contrast, glutamate
disruption leaves hedonic impact unchanged. These results suggest
that corticolimbic glutamate inputs to medial shell can produce
strong motivations but cannot penetrate as effectively into the
hedonic pleasure or displeasure components of emotions gener-
ated by subcortical circuitry.
Results
Synopsis
The effect of medial shell modulation of either GABAergic and
glutamatergic transmission was assessed, for distinct group of
animals, either on hedonic ‘liking’ affective response to sucrose-
quinine taste using the taste reactivity test or on generation of
appetitive or aversive motivated behavior expressed as spontane-
ous emission of naturalistic eating versus defensive treading
behaviors. In this design both GABAergic and glutamatergic
modulation was conducted in the same animals, allowing us to
compare specific effects of each drug on behavioral tests in the
same rat. Both muscimol, the GABA agonist, and DNQX, the
glutamate AMPA antagonist, produced similar rostrocaudal
gradients of appetitive and defensive behaviors that conformed
to an ‘affective keyboard’ pattern (Fig. 2).
However, only stimulation of GABA receptors with muscimol
microinjection generated corresponding shifts in affective reactions
to the hedonic impact of sweet or bitter tastes, whereas glutamate
disruptions had no effect on hedonic impact (Fig. 3). For example,
bittersweet tastes became more positively ‘liked’ (e.g., elicited more
lip licking and similar hedonic orofacial reactions) after rostral
shell microinjections (34.3+/25.88 SEM hedonic reactions on
muscimol versus 19.5+/26.45 SEM on vehicle, F(1,5)=7.888,
p=.038), but became negatively ‘disliked’ (e.g., elicits gapes) after
caudal microinjections (2.00+/2.632 SEM hedonic reactions on
muscimol versus 20.8+/0 5.68 SEM on vehicle, F(1,9)=10.970,
p=.009; 25.3+/22.39 SEM aversive reactions on muscimol
versus 12.9+/22.75 SEM on vehicle, F(1,9)=12.880, p=.006).
Glutamate AMPA blockade with DNQX microinjections com-
pletely failed to alter hedonic ‘liking’ or aversive ‘disliking’
reactions to sensory pleasure or displeasure, despite generating
Figure 1. Glutamatergic and GABAergic NAc Circuits. Green; glutamatergic inputs from medial prefrontal cortex, orbitofrontal cortex,
hippocampus, thalamus, and basolateral amygdala are shown entering the NAc, where they synapse on distal dendrites of medium spiny neurons in
NAc. Red; GABAergic inputs from ventral pallidum and ventral tegmental area, as well as GABAergic interneurons and axon collaterals from other
medium spiny neurons are shown synapsing onto proximal dendrites and soma of medium spiny neurons within NAc.
doi:10.1371/journal.pone.0011223.g001
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similar to GABAergic microinjections.
Fos plume analysis of local drug impact
In order to map where microinjections were likely to have
directly impacted local tissue, and to assign anatomical responsi-
bility for behavioral effects, we used a Fos plume tool applied to
separate rats to measure local plume-shaped regions of neuronal
modulation caused by microinjections of DNQX, muscimol or
each of the vehicles (total n=33) [23,24,25] (Fig. 4). Local plumes
of Fos expression provide a relatively direct measure of the spread
of drug impact on local brain tissue, in the form of immediate early
gene transcription and translation within nearby neurons.
We used a split-and-recombine design to compare behavioral
and neurobiological Fos plume effects of GABA versus glutamate
drug microinjections [23,24,25]. This procedure avoids under-
estimation of drug spread that could result if plumes were assessed
after a series of behavioral tests, due to progressive gliosis induced
by microinjection repetition. Rats were assigned to either
behavioral or Fos analysis groups at the time of surgery.
Each DNQX plume contained a ,,0.08 mm
3 volume center
of quadrupled Fos expression levels (compared to vehicle levels;
DNQX center radius =0.267+/20.042 mm SEM). The plume
center was surrounded by a middle band of tripled Fos expression
(radius =0.528+/20.068 mm SEM), which was surrounded by
an outer rim of doubled Fos levels (radius =0.978 mm).
Muscimol (75 ng) microinjections produced small, inhibitory
‘‘antiplumes’’ [23] of 0.3 mm radius, where local Fos expression
was suppressed below vehicle levels, surrounding an even smaller
excitatory center, consistent with previous reports of muscimol-
induced changes in Fos expression [26]. The very small excitatory
center of doubled Fos expression (volume =,0.004 mm
3;r a d i u s
=0.097+/2.016 mm SEM) was surrounded by the larger inhibitory
antiplume of ,K Fos normal expression (compared to vehicle levels;
volume ,0.04 mm
3;r a d i u s= . 2 0 9 +/20.032 mm SEM), and
further surrounded by an outer weaker anti-plume of ,75% vehicle
Fos expression (volume =,0.11 mm
3; radius =.304+/2.0468 mm
SEM).
In comparison, DNQX produced slightly larger Fos plumes
than muscimol (though reversed in polarity). The larger volume of
the DNQX plume may perhaps be due to the fact that DNQX
was dissolved in a more lipophilic vehicle (DMSO-saline mixture
rather than pure saline), which may have produced greater
diffusion.
Figure 2. Summary maps of appetitive versus defensive motivation produced by GABA-A agonism and AMPA antagonism. Fos
plume maps of appetitive eating versus defensive treading behavior generated by muscimol GABA stimulation (left) or DNQX AMPA blockade (right).
Sites were designated as producing primarily appetitive (green symbols), defensive (red symbols) or mixed (yellow symbols) motivated behavior
following muscimol and DNQX microinjections. Purely appetitive behavior (criteria for including a site was a .400 sec increase in feeding behavior)
was primarily stimulated in rostral shell by both DNQX and muscimol, whereas defensive behavior (criteria for including a site was a .15 sec increase
in treading behavior over vehicle levels) was primarily stimulated in caudal shell by both DNQX and muscimol. Histograms bars show mean change
from vehicle (error bars = SEM) for both feeding (top) and defensive treading (bottom) at all rostrocaudal levels.
doi:10.1371/journal.pone.0011223.g002
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‘‘disliking’’ in medial shell
Muscimol microinjections shifted the positive hedonic impact of
tastes in a keyboard-like gradient pattern, at rostral levels enhancing
positive hedonic reactions but at more caudal levels suppressing the
same positive hedonic reaction and instead amplifying aversive
reactions to tastes (correlation of hedonic reaction change with
rostrocaudal position = r (24)=0.461, p,0.01).
Muscimol microinjection into a relatively far rostral level,
about 0.5 mm thick and located at the level of the genu of the
corpus callosum (+2.0 to +2.4 mm ahead of bregma) enhanced
positive-valence hedonic reactions that are normally elicited by
sucrose taste. Microinjection of muscimol at this rostral level in
medial shell nearly doubled hedonic reactions to the sucrose-
quinine mixture (muscimol =34.3+/25.88 SEM versus vehicle
=19.5+/26.45 SEM tested at 15 min after microinjection;
F(1.5)=7.888, p=.038). The affective keyboard appeared to
have an anterior end, so that hedonic reactions were no longer
significantly enhanced if muscimol sites were moved further
anterior, beyond this +2t o+2.4 rostral level (site X drug
interaction, F(1,13)=9.516, p=.009). That is, if microinjections
were instead below the minor forceps of the corpus callosum,
between +2.4 to 2.8 mm ahead of bregma, muscimol actually
non-significantly decreased hedonic reactions to the taste
mixture (average of 12.0+/24.66 SEM versus 21.1+/25.34
SEM under vehicle, F(1,7)=2.835, p=.136). This far rostral
zone anterior to +2.4 bregma extends into the rostral pole of
NAc, and thus may be outside what is traditionally considered
the medial shell. The rostral pole is further anterior than our
previous fear and feeding gradient studies have typically
mapped. These results suggest that the rostral pole is not part
of the affective keyboard or functional rostrocaudal gradient for
amplifying affective reactions.
When sites were moved posteriorly into the caudal half of shell,
muscimol microinjection suppressed or nearly abolished positive-
valence hedonic reactions that are normally emitted to sucrose
taste (e.g., tongue protrusions and paw licking) at both 15 min and
1 hr after microinjection (15 min: F(1,9)=10.970, p=.009; 1 hr:
F(1,10)=11.962, p=.006; Fig. 3, 5, Fig S1). Supporting a
keyboard-like pattern of affective modulation, muscimol produced
progressively greater suppression of positive hedonic reactions
elicited by oral infusions of sucrose-quinine solution as sites
Figure 3. Summary maps of hedonic and aversive shifts produced by GABA-A agonism and AMPA antagonism. Fos plume maps of
sites where muscimol GABA stimulation (left) or DNQX AMPA blockade (right) produced hedonic (red symbols) or aversive (purple symbols) in
orofacial reactions to a sweet/bitter sucrose-quinine mixture at 15 minutes post-microinjection. Criteria for including a site as hedonic was an increase
.10 in ‘liking’ reactions and a decrease or no change in ‘disliking’ reactions. Criteria for including a site as aversive was an increase .10 in ‘disliking’
reactions and/or a decrease .10 in ‘liking’ reactions. Hedonic enhancement was produced by muscimol only a moderately rostral area just below the
genu of the corpus callosum. Aversive enhancement was produced by muscimol throughout rostral shell, and in an area rostral to the hedonic
enhancement zone, possibly extending into rostral pole of NAc. DNQX produced mostly ambivalent effects (white; no change, or simultaneously
enhanced or suppressed ‘liking’ and ‘disliking’ reactions). Histograms bars show mean change from vehicle (error bars = SEM) for both hedonic
‘liking’ reactions (top) and aversive ‘disliking’ reactions (bottom) at all rostrocaudal levels.
doi:10.1371/journal.pone.0011223.g003
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suppression with caudal placement: r(25)=.461, p=.023).
Simultaneously, in caudal shell, muscimol microinjections
dramatically increased the number of negative-valence aversive
reactions (gapes, headshakes, forelimb flails), which are normally
emitted to quinine taste (15 min: F(1,9)=12.880, p=.006; 1 hr:
F(1,10)=11.165, p=.007, Fig. 3, 5, Fig S1). The number of
aversive reactions progressively increased as sites became more
caudal, and nearly doubled above vehicle levels at the most caudal
sites (muscimol =25.3+/22.39 SEM; vehicle =12.9+/22.75
SEM). In summary, muscimol microinjection in medial
shell generated a rostrocaudal gradient of rostral ‘liking’ and
disliking ‘disliking’, corresponding to the concept of an affective
keyboard.
DNQX fails to clearly modulate ‘‘liking’’ or ‘‘disliking’’
reactions
By contrast, microinjections of DNQX in the shell comp-
letely failed to shift affective ‘disliking’ or ‘liking’ (Fig. 3, 6, Fig
S1). Hedonic or aversive patterns of taste reactivity were
never altered by DNQX microinjection at any rostrocaudal
site (positive hedonic reactions, site X drug interaction,
F(1,22)=.074, p=ns; aversive reactions, site X drug interaction,
F(1,22)=.004, p=ns) or time after microinjection (positive
hedonic reactions =15 min: F(1,23) =.105, p =ns; 1 hr:
F(1,22)=.839, p=ns; negative aversive reactions =15 min:
F(1,23) =.934, p=ns; 1 hr= F(1,22)=1.560, p=ns). At most
a few individual rats showed only noise-like fluctuations at
random sites or tests after DNQX, without any discernable
anatomical keyboard pattern or statistical significance.
Direct contrast of DNQX to muscimol in the same rats for
‘‘liking’’ and ‘‘disliking’’
As each rat was tested with both muscimol and DNQX at its
particular anatomical site, it was possible to directly compare the
effects on taste reactivity of the two neurochemical manipulations
at the same rostrocaudal location in the same rat. Direct contrast
of DNQX and muscimol effects confirmed that muscimol robustly
altered hedonic reactions while DNQX did not (muscimol versus
DNQX, site X drug interaction, 15 minutes, F(1,21)=6.296,
p=.020; 1 hr, F(1,21)=6.957, p=.015). Similarly, muscimol
amplified negative aversive reactions, but DNQX did not, at the
same caudal sites (muscimol versus DNQX, caudal rats,
F(1,9)=8.741, p=.016).
DNQX and muscimol induction of fear and feeding
To confirm the presence of DNQX and muscimol-generated
gradients of feeding and defensive behavior, one group of rats was
tested only for the elicitation of spontaneous motivated behavior,
along with a small subset of the rat that also went through taste
reactivity testing. DNQX and muscimol generated similar patterns of
feeding versus fear behaviors along the rostrocaudal gradient of
motivation valence in medial shell. Rostral microinjections of either
DNQX or muscimol at least quadrupled levels of appetitive eating
behavior and food intake over vehicle control levels (feeding time, site
X drug interaction, DNQX, F(1,14)=8.589, p=.001, muscimol,
F(1,12)=8.159, p=.014; food intake, site X drug interaction,
DNQX, F(1,14)=6.996, p=.016, muscimol, F(1,12)=7.129,
p=.020, Fig. 2, 7). Progressively more rostral microinjections
produced greater levels of feeding and intake (correlation with rostral
Figure 4. Fos plume examples for muscimol and DNQX. Colored plume maps for both muscimol (left) and DNQX (right) show local elevations
or suppressions of Fos caused relative to vehicle (top). Muscimol produces an inhibitory ‘‘anti-plume’’ or an area of suppressed Fos expression (to
75% and 50% of vehicle levels), surrounding a small excitatory center of 200% vehicle levels. DNQX produces a larger, excitatory plume with areas of
200–400% vehicle level Fos expression. Examples of Fos expression produced by both vehicles (saline and the 50% saline/50% DMSO mixture) as well
as muscimol and DNQX are shown on the bottom.
doi:10.1371/journal.pone.0011223.g004
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(14)=.747, p=.001). Microinjection of DNQX or muscimol into
more caudal sites of medial shell did not increase feeding behaviors,
and instead oppositely suppressed feeding behavior at the most
caudal site for both drugs (DNQX, F(1,14)=8.589, p=.001,
muscimol, F(1,12)=8.159, p=.014).
Conversely, caudal microinjections of either drug stimulated
spontaneous generation of fearful behaviors such as robust defensive
treading (site X drug interaction, DNQX, F(1,14)=13.213, p=.003;
muscimol, F(1,12)=21.087, p=.001). As sites became progressively
more caudal, the DNQX or muscimol microinjections produced
increasingly higher levels of defensive treading behavior (correlation
f o rD N Q X :r( 1 6 ) = 2.462, p=.036; muscimol: r(14)=2.682,
p=.004).
While both muscimol and DNQX microinjections produce
similar patterns of feeding and fear behaviors, at rostral and caudal
sites respectively, the intensity with which they did so differed
slightly. There was a direct correlation between site placement
along the rostrocaudal gradient with the intensity of motivated
feeding versus fearful behaviors generated by microinjections, both
for muscimol and DNQX (feeding time, r(14)=.603, p=.011;
treading time, r(14)=.680, p=.004). Yet, DNQX produced
Figure 5. Muscimol induced changes in hedonic and aversive reactions. Fos plume maps of sites where muscimol GABA-A stimulation
produced changes in hedonic ‘liking’ reactions (A) or aversive ‘disliking’ reactions (B) to sucrose-quinine taste at 15 (left) and 60 minutes (right) post-
microinjection. Muscimol primarily enhanced ‘liking’ reactions in a small moderately rostral area, beneath the genu of the corpus callosum. Muscimol
microinjection at sites outside of this area tended to reduce hedonic ‘liking’ reactions and enhanced aversive ‘disliking’ reactions, especially in caudal
regions of NAc medial shell. Histograms bars show mean change from vehicle (error bars = SEM) for both each reaction pattern at rostrocaudal and
dorsoventral levels throughout medial shell.
doi:10.1371/journal.pone.0011223.g005
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time, site X drug interaction, F(1,12)=7.084, p=.021), while
muscimol produced more intense defensive treading behavior at
caudal sites (treading time, site X drug interaction
(F1,12)=36.472, p,.001). In summary, both neurochemical
manipulations produced similar rostrocaudal gradients for gener-
ating positive and negative motivated behaviors, and at similar
overall intensities, but with slightly different valence biases
(glutamate = positive motivation bias; GABA = negative bias).
We note that a limitation of the present results was that only one
dose of DNQX was used to compare motivation and hedonic
effects, and it would be valuable to confirm our conclusions with
additional doses. However, the dose used was chosen to be
maximally effective at generating appetitive and fearful motiva-
tions based on previous results [4], making it perhaps unlikely that
other DNQX doses would modulate hedonic reactions any more
potently than the dose used here.
Discussion
Glutamate signals to NAc convey primarily top-down controls
from cortical and cortex-related structures, such as prefrontal
cortex, hippocampus, basolateral amygdala and thalamic nuclei
embedded in cortico-limbic-thalamo-cortical loops. In contrast,
Figure 6. DNQX induced changes in hedonic and aversive reactions. Fos plume maps of sites where DNQX AMPA blockade produced
changes in hedonic ‘liking’ reactions (A) or aversive ‘disliking’ reactions (B) to sucrose-quinine taste at 15 (left) and 60 minutes (right) post-
microinjection. DNQX had little to no effect on both hedonic ‘liking’ reactions and aversive ‘disliking’ reactions. While some subjects did show
changes in ‘liking’ or ‘disliking’ (as indicated by the sporadically colored symbols), no general pattern emerged. Histograms bars show mean change
from vehicle (error bars = SEM) for both each reaction pattern at rostrocaudal and dorsoventral levels as marked along the medial shell.
doi:10.1371/journal.pone.0011223.g006
Corticolimbic Hedonic Limits
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primarily subcortical inputs from intrinsic local NAc neurons, and
from other subcortical structures such as ventral pallidum. Here
we showed that hyperpolarizing local disruptions of either
corticolimbic glutamate or subcortical GABA inputs to NAc
medial shell generate equivalent motivations expressed in behavior
as appetitive desire and/or defensive dread mixtures, along the
same rostrocaudal gradient in medial shell. But only GABA-
related disruptions by muscimol additionally produced corre-
sponding changes in the hedonic impact of an affect-laden
gustatory stimulus. By contrast, glutamate-related disruptions by
DNQX did not influence hedonic impact.
The valence of motivation (appetitive versus fearful) and of
hedonic impact (pleasant versus unpleasant) generated by amino
acid neurotransmitter disrupting microinjections was always
determined by the rostrocaudal position of the microinjection site
within the affective keyboard of NAc medial shell. In this keyboard
pattern, each microinjection corresponded to a key, the size of
which was the radius of the local Fos plume that surrounded the
drug site. Each microinjection key was valence-tuned to a graded
mixture of desire and/or dread corresponding to its rostrocaudal
keyboard site in medial shell. Glutamate-related hyperpolariza-
tions by DNQX actually produced a local plume of roughly three
times larger radius (0.9 mm for outer radius of detectable Fos
change) than GABA-related muscimol microinjections (0.304 mm
radius), yet muscimol produced a broader array of functional
effects.
DNQX microinjections and muscimol microinjections generat-
ed similar patterns of motivated fear or feeding behaviors. At
rostral sites in medial shell, DNQX or muscimol each stimulated
eating behavior and food intake to four times above vehicle control
levels. Disruptions in medial shell completely failed to distort
hedonic ‘liking’ or aversive ‘disliking’ reactions to sucrose-quinine
taste, despite generating levels of motivated fearful or feeding
behaviors intense as intense as muscimol. At caudal sites, DNQX
or muscimol each generated fearful behaviors: chiefly defensive
treading directed mostly at the front of the chamber and objects in
the room beyond, at levels that often exceeded 10 times control
vehicle levels. Eating behavior and food intake gradually declined
and fearful behaviors gradually rose as sites moved progressively
from rostral to caudal in medial shell.
However, only GABA disruptions generated a corresponding
rostrocaudal gradient of shifted hedonic impact from sensory
pleasure to displeasure. Muscimol microinjection at a rostral level
enhanced positive ‘liking’ reactions to a bittersweet taste (e.g., lip
or paw licking), whereas as sites moved caudally muscimol
microinjections oppositely increased negative ‘disliking’ reactions
(e.g., gapes) and suppressed positive ‘liking’ reactions. DNQX
microinjections completely failed to alter ‘liking’ reactions to
sweetness, and DNQX at sites in caudal shell completely failed to
enhance negative ‘disliking’. Thus local glutamatergic AMPA
blockade in medial shell powerfully induced motivated ‘wanting’
to eat, fearful anti-predator behaviors, or both, but never altered
the hedonic impact of a sensory pleasure or displeasure.
The difference between effects on motivated desire-dread versus
on hedonic ‘liking’-‘disliking’ reactions suggests that glutamate and
GABA signals similarly can activate a motivation-generating
keyboard in NAc to produce fear or feeding-related behaviors.
But only GABA signals have additional access to a hedonic-
generating keyboard corresponding to core affective reactions to
sensory pleasure or displeasure.
Neurobiological differences between GABAergic and
glutamatergic microinjections
Muscimol microinjections stimulate GABAA receptors and
might be expected to produce hyperpolarization and reductions
in the firing rate of local neurons containing GABAA receptors.
GABAA stimulation by muscimol produces inhibitory hyperpolar-
izations by allowing Cl- to enter the cell [27], producing especially
powerful inhibition of medium spiny neurons [28].
By comparison, DNQX microinjections block glutamatergic
AMPA receptors, and might have been expected to similarly
produce relative hyperpolarization of neurons containing gluta-
mate receptors, by diminishing ‘‘up states,’’ suppressing EPSPs,
and reducing the number of action potentials produced
[29,30,31,32,33,34,35].
However, important differences also exist between GABAergic
and glutamatergic hyperpolarizations. Muscimol may more
potently hyperpolarize NAc neurons by acting on GABAA
receptors located on somata and proximal dendrites [36,37,38].
DNQX generation of desire and dread requires interaction with
endogenous dopamine at the same site [3,4,5] and may act more
distally on medium spiny dendrites, blocking ionotropic glutamate
signals at distant spines, where AMPA receptors are more likely to
be found [37,39,40,41]. More distal placement of glutamate
receptors on the head of neuronal spines, compared to GABA
receptors, also might dilute the intensity of IPSP states at the soma
and axon hillock induced by glutamatergic blockade, altering the
degree of disinhibition passed on to output targets such as ventral
pallidum, lateral hypothalamus or ventral tegmentum. The most
potent hyperpolarizations may come via activation of fast-spiking
interneurons which, in striatum, produce IPSCs in the postsyn-
aptic neurons of 4 to 6 times the amplitude of those produced by
medium spiny neurons [28]. One factor which may account for
these intense differences in amplitude is synaptic location:
parvalbumin-positive terminals, which likely arise from fast-spiking
interneurons, are more likely to synapse on the soma, whereas
medium spiny neurons are more likely to end on dendrites or
spines [28,42]. Generally, it seems the more proximal or intrinsic
the input, the greater the inhibitory impact. All this implies that
subcortical GABA inputs to NAc may achieve a greater potency of
disinhibition of downstream targets to alter hedonic impact than
glutamate inputs from predominantly cortical-related sources.
Finally, we note that muscimol microinjection produced
‘‘antiplumes’’ or areas of Fos suppression, whereas DNQX
produced robust pure plumes of elevated Fos expression,
consistent with our previous observations [2,26]. These consider-
ations suggest an additional qualitative difference between
glutamatergic versus GABAergic hyperpolarizations, beyond a
simple intensity difference, which may also contribute to differing
modulation of hedonic reactions to sensory pleasure or displea-
sure.
As a caveat, it may be important to note that our conclusion
that glutamate disruption fails to penetrate core ‘liking’ reactions
Figure 7. Muscimol and DNQX-induced feeding and defensive treading behavior. Fos plume maps of appetitive eating (A) and defensive
treading (B) behavior generated by muscimol GABA stimulation (left) or DNQX AMPA blockade (right). Scatter plots above Fos plume maps indicate
behavioral changes exhibited by individual subjects; lines indicate the slope of the correlation between behavioral change (from vehicle) and
distance rostral to bregma in mm (*p,.05; **p,.01). Histograms bars below and to the sides of the maps show mean change from vehicle (error bars
= SEM) for each behavior at rostrocaudal and dorsoventral levels as marked along the medial shell.
doi:10.1371/journal.pone.0011223.g007
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in particular to those requiring AMPA receptor activation.
Blockade of AMPA receptors may be expected to disrupt
ionotropic fast excitatory signals to medium spiny neurons in
medial shell. This conclusion about fast-acting ionotropic
receptors may need to be distinguished from metabotropic
glutamate receptors that play a slower and broader modulatory
role for neuronal function, and which could conceivably alter
hedonic ‘liking’ more effectively than AMPA blockade, either
directly by altering medium spiny neurons with metabotropic
receptors or via presynaptic modulation of GABA release, which
could in turn alter hedonic impact [43,44]. Thus, we conclude that
ionotropic AMPA glutamate disruptions in NAc shell do not
modulate hedonic pleasure, but consider the hedonic role of
metabotropic glutamate receptors to remain an open empirical
question.
Limits to top-down control?
An overall interpretation of our results may be that top-down
corticolimbic inputs using glutamate signals from prefrontal cortex
regions, such as infralimbic cortex (homologous in rats to ventral
anterior cingulate cortex in humans), orbitofrontal or prelimbic
cortex, or from hippocampus subiculum, basolateral amygdala, or
paraventricular thalamus, all are limited in their ability to control
hedonic emotional processes generated by NAc neurons, com-
pared to bottom-up or subcortical inputs to the same NAc sites
that primarily use GABA signals. Specifically, corticolimbic
glutamate circuits appear to control the generation in medial shell
of motivation components (incentive salience versus fearful
salience), but not the generation of hedonic affective states
(pleasure ‘liking’ versus displeasure ‘disliking’). This may restrict
the capacity of top-down corticolimbic circuits to regulate
subcortically generated emotion. Of course, another caveat is that
our studies were conducted in rats, whereas primates and
especially humans have larger prefrontal cortex and thus more
dense glutamate projections to NAc. However, our results are still
likely to apply to humans unless the quantitative species difference
in top-down influence actually creates a qualitative expansion of
control to include NAc-generated hedonics.
We conclude that the influence exerted by top-down controls
over NAc may be limited to motivational states, and may leave
core hedonic reactions to affective events relatively untouched.
This feature might also conceivably set limits on the range of
emotional processes that can be effectively adjusted by cognitive
therapies that recruit top-down circuits [45,46,47,48,49,50,51,52].
As caveat to our general distinction between cortical glutamate
versus subcortical GABA sources, it is important to note one
significant subcortical source of glutamate signals in NAc: co-
release of glutamate by mesolimbic dopamine neurons [53].
Glutamate released by mesolimbic dopamine neurons can
produce fast postsynaptic potentials in NAc that is blocked by
DNQX, implicating ionotropic AMPA receptors [53]. It may be
noteworthy that dopamine in NAc, like glutamate AMPA
disruption, fails to enhance ‘liking’ reactions to sensory pleasure
even when it elevates ‘wanting’, suggesting a functional similarity
between ionotropic glutamate and dopamine actions in NAc
[54,55]. Also, endogenous dopamine is required for local AMPA
glutamate blockade by DNQX to generate either motivated fear
or feeding behaviors, again suggesting a synergistic interaction for
dopamine-glutamate motivation effects in medial shell.
In contrast to glutamate disruption from any source, both
motivation and hedonic impact are robustly generated together by
GABAergic inhibition of neurons in medial shell, produced by
inputs from neighboring medial spiny neurons and other intrinsic
NAc neurons, or from GABAergic inputs from other subcortical
structures [1,56]. The ability of GABAergic inhibition to modulate
hedonics is consistent with previous work on NAc generation of
‘liking’ and ‘disliking’, and also with related hedonic generation by
the ventral pallidum, a major source of GABAergic input and
output from NAc [23,57,58,59].
Conclusion
Both corticolimbic glutamate and subcortical GABA signals in
medial shell can stimulate motivated behaviors reflecting appeti-
tive and/or fearful motivations, organized rostrocaudally along an
affective keyboard of desire versus dread in medial shell. At normal
intensity levels, such amino acid neurotransmitter signals may act
on valence-coded locations in rostral medial shell to help give
healthy attractiveness to rewards and zest to life, whereas at
excessively higher levels may contribute to compulsive drug
addiction and related compulsive pursuits [56,60]. Likewise, in
caudal shell, GABA and glutamate signals may normally function
to adaptively make threat-related stimuli frightening in appropri-
ate situations, but at excessively higher levels contribute to levels of
pathological paranoia in schizophrenia and related disorders
[61,62,63,64,65,66].
Yet despite the similarity of motivational effects of top-down
and bottom-up signals using amino acid neurotransmitters, the
core hedonic components of emotions generated in medial shell
may differ qualitatively between them. Hedonic components of
‘liking’ reactions to pleasant sensations and ‘disliking’ reactions to
unpleasant ones may be generated uniquely by subcortical inputs
to the hedonic–generating keyboard for amino acid signals in
medial shell, such as collaterals from neighboring intrinsic
neurons, accumbens-pallidal loops, brainstem inputs and related
projections [67,68,69,70,71,72].
Our results are compatible with the hypothesis that the capacity
of top-down corticolimbic circuits to regulate emotion generation
has qualitative limits. We conclude that corticolimbic regulation of
emotion might be more effective at modulating motivation




Rats [n=67 (behavioral testing, n=36; Fos plume, n=31),
male, 280–320 g at surgery], were housed on a 12 hr light/dark
reverse cycle (,21uC) with ad libitum food (Purina Rat Chow) and
water (tap water).
Microinjection cannulae surgery
Rats were implanted bilaterally with stainless-steel guide
cannulae at various rostrocaudal points in the medial shell of
NAc. For each rat, the rostrocaudal point was arbitrarily assigned
and bilaterally matched t to be symmetrical on left and right sides,
but from rat to rat rostrocaudal assignments were staggered so that
the group’s placements as a whole filled the entire anteroposterior
extent of medial shell. Rats were anesthetized with ketamine
(80 mg/kg), xylazine (5 mg/kg), pre-treated with atropine
(0.04 mg/kg), and positioned in a stereotaxic apparatus (David
Kopf Instruments, Tujunga, CA). A slanted skull position was used
to avoid penetrating the lateral ventricles, with the incisor bar set
at 5.0 mm above interaural zero. Chronic bilateral microinjection
guide cannulae (23 gauge; stainless steel) were positioned to end
2 mm above each target site in the medial shell [73]. Rostral shell
placements were generally centered around the anteroposterior
(AP) coordinates AP +3.4 (61) mm ahead of bregma, caudal shell
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bregma. In other dimensions, all mediolateral (ML) and
dorsoventral (DV) coordinates were ML 61 mm and DV-
5.7 mm below the skull. Guide cannulae were anchored to the
skull with four bone screws and acrylic cement, and stainless steel
obturators were inserted into guide cannulae to prevent occlusion.
A subset of rats (n=26) designated for taste reactivity testing, also
received implantation of oral cannulae for the infusion of taste
solutions. Polyethylene tubing was inserted just lateral to the first
maxillary molar and run subcutaneously along the zygomatic arch
to the top of the skull, where it exited through an incision. There,
the tubing was secured to 15 mm, 19 gauge stain-less steel
cannulae with wiring and dental acrylic. Post-surgery, each rat
received chloramphenicol sodium succinate (60 mg/kg) or pro-
phylactic penicillin (aquacillin; 45, 000 U, i.m.) to prevent
infection, and buprenorphine hydrochloride (0.3 mg/kg) for pain
relief. Rats were allowed to recover for at least 7 d before
behavioral testing.
Drugs and Microinjections
Glutamate AMPA receptor blockade was achieved by micro-
injection of the AMPA/kainate glutamate receptor antagonist,
DNQX (6,7-dinitroquinoxaline-2,3(1H,4H)-dione; Sigma, St.
Louis, MO), dissolved in 50% DMSO/50% 0.15 M saline, at a
dose of 450 ng/0.5 ml per side. This DNQX dose was the same
used to produce rostrocaudal gradients of eating and defensive
treading behaviors via microinjections into medial shell in recent
studies [2,3,4]. GABAA receptor activation was achieved by
microinjections of muscimol (Sigma, St. Louis, MO) dissolved in
0.15M saline at 75 ng/0.5 ml per side, which was chosen
according to previous results [5]. The third and fourth
microinjection conditions were vehicle controls: the 50%
DMSO/50% 0.15 M saline mixture used for DNQX solutions
and the 100% 0.15M saline vehicle used for muscimol. The pH of
all solutions was maintained between 7.0 and 7.4.
After 3 d of handling, rats were habituated to the test chambers
for 3 consecutive days, and were given a vehicle microinjection
(saline) on the last day of habituation. Each rat was subsequently
tested with all 4 microinjection conditions in counterbalanced
order, in test sessions spaced 48 hours apart. Microinjection
cannulae (29 gauge) which extended 2.0 mm beyond the ventral
tip of the guide, were attached to a syringe pump via PE-20 tubing
and inserted into the guide cannulae. Rats were gently hand-held
while they were bilaterally infused with a microinjection volume of
0.5 ml at a rate of 0.3 ml/min. After infusion, the injectors
remained in place for an additional 60 sec to allow for drug
diffusion before their withdrawal and replacement of the
obturators. The rat was placed immediately into a behavioral
testing chamber.
Behavioral Taste Reactivity Tests
For taste reactivity tests, immediately following drug microin-
jection, a polyethylene delivery tube was connected to the rat’s
oral cannulae. Rats were placed into the test chamber, which had
a transparent floor, under which an angled mirror reflected an
image of the rat’s ventral face and mouth into a digital video
camera. At 15 min and 60 min post-microinjection, a solution
containing a mixture of sucrose and quinine (0.1 M sucrose and
1.66610
24 M quinine) was infused in 1 ml volume over a 1 min
period via syringe pump connected to the delivery tube. The
sucrose-quinine mixture was used in order to elicit both positive
hedonic reactions (‘liking’) and negative aversive reactions
(‘disliking’) in the same session.
Taste Reactivity Video Scoring
Hedonic, aversive, and neutral response patterns were later
scored off-line in slow motion (frame by frame to 1/10
th actual
speed) by a trained observer who was blind to the drug condition
and cannulae placement, using procedures developed to compare
hedonic and aversive taste reactions [74]. Hedonic or positive
responses included rhythmic midline tongue protrusions, lateral
tongue protrusions, and paw licks. Aversive or negative responses
included gapes, head shakes, face washes, forelimb flails, and chin
rubs. Neutral responses include the relatively non-valenced
behaviors or passive dripping of solution out of the mouth,
ordinary grooming, and rhythmic mouth movements. All video
analyses were conducted blind to drug condition and cannulae
placement using Observer software (Noldus, Netherlands). A time
bin scoring procedure was used to ensure that taste reactivity
components of different relative frequency were balanced in their
contributions to the final affective hedonic/aversive totals [74].
For example, rhythmic mouth movements, passive dripping of
solution, paw licking, and grooming behaviors typically occur in
long bouts, and were thus scored in 5 s time bins (up to 5 s
continuous bout duration equaled one occurrence). Rhythmic
tongue protrusions along the midline, which occur in shorter
bouts, were scored in 2 s time bins. The other behavioral
components (lateral tongue protrusions, gapes, forelimb flails,
head shakes, chin rubs) typically occur as discrete events and were
therefore scored as single occurrences each time they appeared
(e.g., one gape scored as one occurrence). Individual totals were
calculated for hedonic and aversive categories for each rat by
adding all response scores within an affective category for that rat.
Behavioral tests of fear and feeding
On a test day, rats received one of the microinjection conditions
described above (DNQX, muscimol, 50% DMSO/50% 0.15 M
saline, 100% 0.15 M saline) and were immediately placed in a
transparent test chamber, where spontaneous behavior was
videotaped for 60 min and saved for subsequent off-line analysis
[4,5]. To support eating and drinking behaviors, the chamber
contained a dish of pre-weighed food chow pellets (,20 g) and a
water bottle. To support defensive treading behavior, the floor was
covered with granular bedding (crushed corn cob) spread 3 cm
deep. Behavior was analyzed in slow-motion by an observer blind
to drug content and microinjection site in (1) eating, (2) drinking,
(3) defensive treading, (4) grooming, (5) burrowing (insertion of
head under corn-cob bedding, with downward and forward
thrust), (6) burrow treading (combination of burrowing head thrust
and paw-treading movements), (7) rearing, (8) locomotion (crossing
of lines that divide six grid squares superimposed on floor of test
chamber). For each behavior, a total of cumulative time (seconds)
spent engaged in that action was assessed.
Within-rat comparison: To compare elicitation of fear versus
feeding motivations on a within-subject basis to shifts in hedonic
‘liking’ versus ‘disliking’, a group of 6 rats from the taste reactivity
group were selected to confirm rostrocaudal gradients of
spontaneous generation of motivated eating versus fearful
behaviors. After taste reactivity testing, this group was additionally
tested for the elicitation of spontaneous motivated feeding
behavior versus fearful treading as described above.
Histology
After the completion of testing, rats used for behavioral testing
were deeply anesthetized with sodium pentobarbital and their
brains were removed and fixed in 10% paraformaldehyde
overnight and then cryoprotected in 20% sucrose for at least 2
d. Brains were coronally sectioned (60 mm) mounted on slides and
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Cannulae placements were mapped onto drawings of the Atlas
[73]. We considered a site to be rostral if it was located from +1.8
to +3.0 AP relative to bregma (including the rostral pole, between
+2.4 to 3.0 mm). A site was considered to be caudal if it was
located from +0.48 to +1.68 mm AP. To reveal rostrocaudal
gradients more continuously, we also mapped each microinjection
cannulae at its corresponding atlas location, as determined
histologically, and a) continuously plotted behavior evoked at
each location using color scales and b) compiled bar graphs to
summarize behavioral intensities evoked at 6 rostrocaudal
increments.
Fos plume mapping procedure
Brains were processed for Fos-like immunoreactivity, 75 min
after microinjections. DNQX and muscimol Fos plumes were
mapped based on the percentage change in Fos-like immunore-
activity surrounding injections sites after DMQX or muscimol vs.
vehicle controls, measured in blocks along each radial arm
(excitatory plume =200% and 300% elevations above control
levels; inhibitory antiplume =25 and 50% decline from control
levels). Baselines were measured in intact brains to assess normal
expression, and around the site of vehicle microinjections
(Figure 2). Nearby slices were stained for Substance P to identify
landmarks for comparison to a brain atlas [75].
Fos plumes were visualized by immunofluorescence processing,
using NDS, goat anti-cfos and donkey anti-goat AlexaFluor 488
(excitation=488 nm, emission=519 nm; Molecular Probes-
Invitrogen, Carlsbad, CA) as described previously
[2,3,23,24,25,76]. The size of plume symbols used for mapping
was based on the average radii of Fos plumes for that drug. The
color of each plume symbol was coded to show the change in
behavioral effects produced by drug microinjection at the
corresponding site in a particular animal. Both bilateral cannulae
were plotted for each rat to depict every placement (2 sites per rat).
Supporting Information
Figure S1 Muscimol and DNQX-induced changes in hedonic
and aversive reactions. Hedonic (A) and aversive (B) reactions
induced at 15 and 60 minutes post-microinjection, in saline,
muscimol, DMSO/saline and DNQX drug conditions. Overall
rostral rats (left) showed little overall changes in either behavior,
whereas caudal rats (right) showed hedonic suppression and
aversive enhancement (*p,.05; **p,.01). Error bars represent
SEM.
Found at: doi:10.1371/journal.pone.0011223.s001 (4.78 MB EPS)
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